LabRoots is pleased to announce the 10th Annual Laboratory Animal Science Virtual Conference which will take place on February 10, 2021. This is a premier online-only conference that will bring together scientists from basic sciences to bioinformatics, clinicians, veterinary technicians, veterinarians, technical support staff and compliance personnel from around the world to learn about recent advances and challenges in drug discovery and development.
The North American 3Rs Collaborative (NA3RsC) and New Jersey Association for Biomedical Research (NJABR) have planned a program to increase awareness and understanding of relevant 3Rs concepts (Refinement, Reduction, and Replacement). This year's theme is: From Theory to Practice, Tools & Considerations for Implementing the 3Rs.
Topics will include:
This track will cover tools and strategies available to implement the 3Rs for in vivo studies and measure success. You will hear from leaders in the field on a variety of topics including robust study design and refinements in animal handling and assessment.
Microphysiological Systems (MPS):
This track will provide an overview of available MPS technologies, considerations for using these technologies, and practical examples of application. MPS are emerging technologies (spheroids, organoids, and organs-on-chips) that hold potential to increase translation and possibly serve as replacement or reduction for some animal models.
Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open for 2 years from the date of the live event, and the webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global scientific community with a high degree of interaction through live-streaming video and chat sessions.
Like the 2020 conference, this event will be produced on our robust platform, allowing you to watch, learn and connect seamlessly across all desktop or mobile devices. Equipped with gamification and point system, you can now move around the entire event, earning points for a chance to win one of LabRoots' most popular T-shirts.
Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary and discuss results with interested colleagues through email. Plan now to have your poster included in the 2021 Laboratory Animal Sciences Virtual Event. You can submit your abstract here, and submission is free.
RACE Continuing Educational Credits
The 2021 conference has been approved by the American Association of Veterinary State Boards for Continuing Education for veterinarians and veterinary technicians to offer RACE CE credits, and will also meet AALAS and CALAS continuing education criteria.
Use #Lrlas to follow the conversation!
Cassiano Carromeu is the Director of Research and Development at StemoniX and is an expert in neuroscience and stem cell biology. He did his post-doctoral training at UC San Diego using induced Pluripotent Stem Cells (iPSCs) to model autism in vitro and helped to unveil some key aspects of Rett Syndrome and MeCP2 Duplication Syndrome. He joined StemoniX in 2016, where he has translated his expertise into products with the goal of facilitating drug discovery in neuroscience. His efforts led to the current microBrain products offered by StemoniX.
Kamm is the Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering at MIT, where he has served on the faculty since 1978. Kamm has long been instrumental in developing research activities at the interface of biology and mechanics, formerly in cell and molecular mechanics, and now in engineered living systems. Current interests are in developing models of healthy and diseased organ function using microfluidic technologies, with a focus on vascularization. Kamm has fostered biomechanics as Chair of the US National Committee on Biomechanics (2006-2009) and of the World Council on Biomechanics (2006-2010). He currently directs the NSF Science and Technology Center on Emergent Behaviors of Integrated Cellular Systems. He has received numerous awards including the American Society of Mechanical Engineers Lissner Medal (2010) and the ESB Huiskes Medal (2015), both for lifetime achievements, and is the inaugural recipient of the ASME Nerem Medal for mentoring and education. In 2020 he received the Shu Chien Award from the Cell and Molecular Engineering Division of the Biomedical Engineering Society. He was elected to the National Academy of Medicine in 2010. Kamm is co-founder of two companies, Cardiovascular Technologies, and AIM Biotech, a manufacturer of microfluidic systems for 3D culture.
Dan Huh is an Associate Professor in the Department of Bioengineering at the University of Pennsylvania. He is a pioneer of organ-on-a-chip technology, and his research group at Penn focuses on developing microengineered models of human physiological systems for biomedical and environmental applications. Dr. Huh has won several honors and awards including the Bernard Langer Distinguished Lectureship, Lush Prize, the McPherson Distinguished Lectureship, CRI Technology Impact Award, John J. Ryan Medal, Design of the Year Award and Best Product of the Year Award from London Design Museum, NIH Director’s New Innovator Award, Analytical Chemistry Young Innovator Award, TEDx Fellow, NC3Rs Annual Award, Lifetime Membership from the MOMA, SLAS Innovation Award from the Society for Lab Automation and Screening, Scientific Breakthrough of the Year Award from American Thoracic Society, Best Publication Award and Best Postdoctoral Award from the Society of Toxicology, Wyss Technology Development Fellowship from Harvard, Distinguished Achievement Award from Michigan, Widmer Award from microTAS, and Horace H. Rackham Predoctoral Fellowship.
F. Claire Hankenson is Director of Campus Animal Resources and the Attending Veterinarian at Michigan State University. She holds a faculty position as Professor of Laboratory Animal Medicine within the Dept. of Pathobiology and Diagnostic Investigation at the College of Veterinary Medicine. Dr. Hankenson obtained her veterinary degree from Purdue University, completed her graduate work and residency at the University of Washington, Seattle, and then became a Diplomate of the American College of Laboratory Animal Medicine (ACLAM) in 2002. Dr. Hankenson has been active on committees within AALAS since 2002, served on the Executive Board for ACLAM, including ACLAM President in 2015, and is an ad-hoc specialist with AAALAC. In addition, she is currently a member of the PRIM&R Board of Directors. Her research interests include exploration of refinements in laboratory animal practice with mice and rats, including genotyping methods, rodent surgery support, thermoregulation issues and humane endpoints.
James (Jay) Hoying is a Partner and Chief Scientist with Advanced Solutions Life Sciences with more than 25 years of experience in basic and applied biological sciences with a focus in the tissue biology and tissue vascularization. Previously, he was Professor and Chief of the Division of Cardiovascular Therapeutics at the Cardiovascular Innovation Institute (CII) where he developed a broad background in tissue fabrication, cell therapeutics, and translation of discoveries to industry and the clinic. Dr. Hoying is an inventor of the AngiomicsTM microvessel technology and holds numerous patents related to vascularizing tissues and related cell-based therapies. Dr. Hoying received his BA and MS degrees in Biology and Molecular Biology from Case Western Reserve University and his PhD in Cardiovascular Physiology, with an emphasis on the microcirculation, from the University of Arizona. Following this, Dr. Hoying served as a New Investigator in the National Institutes of Health Program of Excellence in Molecular Biology of the Heart and Lung (POEMB). He currently serves on the Editorial staff of two national scientific journals and reviews for several other national and international journals. Dr. Hoying reviews individual and program grant proposals for the National Institutes of Health, the Veterans Affairs, the American Heart Association, and international funding agencies. Dr. Hoying is also a Fellow of the American Heart Association.
Dr. Graham is an Associate Professor in the Departments of Surgery in the Medical School and Veterinary Population Medicine in the College of Veterinary Medicine at the University of Minnesota. She is the Director of the Preclinical Research Center (PCRC) and holds the Robert and Katherine Goodale Chair in Minimally Invasive Surgery. She earned her M.P.H in Epidemiology from the University of Minnesota and her Ph.D from Utrecht University. Her research is centered on the development of cell-based therapies for the treatment of diabetes, specifically induction of immune tolerance and extrahepatic delivery of islets. Dr. Graham is also widely recognized for her expertise in the characterization and refinement of animal models of chronic disease to enhance translation to the clinic. This work proved pivotal in the first demonstration of successful long-term diabetes reversal after adult pig islet xenotransplant and immunosuppression-free allotransplant in primates. Dr. Graham serves on the Board of Directors for the North American 3Rs Consortium and the Academy of Surgical Research. She participates in the NIAID Nonhuman Primate Transplantation Tolerance Cooperative and NIAID Immunobiology of Xenotransplantation Cooperative Research Program. Her research is supported by the State of Minnesota, JDRF, and NIH.
Jane Hurst heads the Mammalian Behaviour & Evolution research group at the University of Liverpool. After gaining her PhD at the University of Birmingham for studies on the behaviour and ecology of wild house mice, she gained a series of three personal postdoctoral fellowships at the University of Nottingham before being appointed to a Research Chair in the Veterinary Faculty at the University of Liverpool in 1998. Her main research interests are in mammalian scent communication, rodent behaviour and ecology, and animal welfare. She was awarded the Association for the Study of Animal Behaviour 2017 medal for her contributions to animal behaviour research. Her research on refined methods for handling mice was awarded the NC3Rs 2010 prize, the Swiss Laboratory Animal Science Association’s 2019 Refinement prize, and an OBE for services to animal welfare in 2020. Currently, she is a Board member of the UK National Centre for 3Rs (NC3Rs), Deputy Chair of the Biotechnology and Biological Sciences Research Council (BBSRC) Appointments Board, and a member of the Royal Society’s Research Appointment Panel.
Kiirsa Pokryfke is the Managing Director of the Unit for Laboratory Animal Medicine (ULAM) Training Core at the University of Michigan. Kiirsa has served in this role for 10 years and is responsible for the supervision of nine trainers and two administrative assistants. The Training Core is responsible for training over 3800 research and animal care personnel on the proper care, treatment and use of animals in laboratory animal science. Previously, Kiirsa Pokryfke was a Training Group Leader and Research Associate at a contract research organization for 11 years prior to working at the University of Michigan. Kiirsa’s laboratory science interests include: training, animal enrichment, animal social housing practices, and, writing and editing SOPs and documents. She earned her BS in Biology from Western Michigan University and completed a graduate degree in Strategy, Management and Leadership from Michigan State University.
Jens completed his undergraduate degree at Heidelberg University in Germany before working as a visitor in Adam Bass’s lab at the Dana-Farber Cancer Institute in Boston. Here, he worked on drug sensitivity and signalling in gastric cancer. Jens performed his master’s studies in Oncology at the University of Oxford, working on targeted therapy combinations in colorectal cancer with Sir Walter Bodmer. Currently, Jens is a PhD candidate in Hans Clevers’s group at the Hubrecht Institute, where he is utilizing human and murine gastrointestinal organoids to study epithelium-microenvironment interactions through co-cultures. A particular focus of his research is the interaction of gut microbes with human colonic and colon cancer organoids. Furthermore, he is working on the development of non-mammalian organoid systems.
Dr. Roldan works as a lead scientist and project manager at AlveoliX since 2019. She is currently responsible for the development and implementation of microphysiological system/organ-on-chip approaches for early- and late-phase drug development. Her research involves generating human models of the distal airways that can be used for safety, efficacy, and inhalation toxicology testings. Dr. Roldan has experience in lung biophysics and physiology, focusing on the homeostasis of the pulmonary surfactant system. Along her Ph.D. journey in Prof. Perez-Gil's lab (UCM, Spain), Dr. Roldan gained extensive knowledge on the interplay of surfactant components for adapting the pulmonary function the relevance of its tight regulation by alveolar cells to preserve alveolar mechanics. Driven by her interest in implementing and investigating the dynamic feature of the lung in vitro as an alternative to animal models, Dr. Roldan jumped into the organ-on-chip field in 2018 by joining Prof. Guenat's lab at the University of Bern (Switzerland). During her postdoctoral work, she led the establishment of an alveolar model for acute lung injury, for which she combined human alveolar and immune cells using lung-on-chip technology. Dr. Roldan holds a BSc. in Biotechnology by the Pablo de Olavide University (Spain) and an MSc. in Biochemistry, Molecular Biology, and Biomedicine by the UCM (Spain).
Jessica Stukes is a native of Charlotte, NC and a proud graduate of North Carolina A&T State University. After completing her Bachelors of Science in laboratory animal science, Jessica begin an intentional journey to experience multiple facets within the field to gain a perspective that would be beneficial to a training/compliance position she's always desired. Along the journey, she's worked as animal husbandry care tech at UNC Chapel Hill, research tech performed non-human primate anesthesia with PET (positron emission tomography) imaging at Wake Forest University, transgenic mouse colony manager, study director and principal investigator at CRO's and breeding tech, transfer specialist and now education & training manager all at Duke University. In addition to her education and over 20 years of experience, Jessica brings a passion for teaching and an eagerness for everyone to "get it". She always makes time to help others get a better understanding of all things lab animal careers and life.
Robert received his PhD in Biochemistry from the Leiden University Center on a molecular study of oncogenic transformation. He continued his scientific career as Postdoc at Stanford University (USA). Upon his return to the Netherlands, he joined the group of Hans Clevers at the Hubrecht Institute studying adult stem cells. In the group of Hans Clevers, he was part of the team that developed the ground-breaking technology that allowed the expansion of adult stem cells in vitro. The so-called Organoid Technology became the basis of the company Hubrecht Organoid Technology (HUB) of which he is currently the CEO.
Paulin Jirkof studied biology with a focus on Zoology in Germany. She obtained her PhD in Neuroscience at the University of Zurich, Switzerland and a Master of Advanced Studies in Management, Technology, and Economics at the ETH, Zurich, Switzerland. Her scientific field of interest is in the implementation and evaluation of severity assessment tools and the reliable assessment and treatment of pain in laboratory rodents. Currently she works as 3R coordinator at the Department for Animal Welfare and 3Rs of the University of Zurich. She is chair of the executive board of the Swiss 3R Competence Center and board member of the Swiss Society for Laboratory Animal Science.
Dr. Malbrue is a native of Baton Rouge, LA. He completed his veterinary school training at Tuskegee University and then went on to complete a residency program in Laboratory Animal Medicine at Louisiana State University. In conjunction with his residency program Dr. Malbrue also completed a Master’s of Science degree in Biomedical and Veterinary Medical Sciences through the Department of Pathobiological Sciences at Louisiana State University and became a Certified Aquatic Veterinarian (WAVMA). He is currently a clinical veterinarian for The Abigail Wexner Research Institute at Nationwide Children’s Hospital (Animal Resources Core) in Columbus, OH where he oversees the rodent and aquatic medicine programs. He additionally is an assistant professor-adjunct in the Department of Preventative Medicine, College of Veterinary Medicine for The Ohio State University and an officer (Rank-Captain) in the U.S. Army (Reserve) Veterinary Corp for the 7356th Veterinary Detachment. His research interest includes methods to improve diversity and wellness in veterinary medicine, aquatic clinical medicine, and implementation of the three R’s (replacement, reduction, and refinement) in biomedical research.
Esther Pearl is the Programme Manager for Experimental Design at the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), which she joined in 2018. Esther’s work includes development of the Experimental Design Assistant, an online tool to guide researchers through the design of in vivo experiments, and the ARRIVE guidelines, which encourage improved design and reporting of animal research. Esther completed a PhD in Biochemistry at the University of Otago, New Zealand and worked as a postdoctoral researcher in the field of developmental biology at the Clinical Research Institute of Montreal, Canada, the Marine Biological Laboratory, USA, and King’s College London, UK.
ABSA International (ABSA) was founded in 1984 to promote biosafety as a scientific discipline and serve the growing needs of biosafety professionals throughout the world. Its goals are to provide a professional association that represents the interests and needs of practitioners ...See more See less
Envigo provides the broadest range of research models and related services to the pharmaceutical and biotechnology industries, government, academia, and other life science organizations. As the largest organization that is solely dedicated to providing research models and related ...See more See less
The North American 3Rs Collaborative (NA3RsC) is a nonprofit organization whose mission is to advance science, innovation, and research animal welfare. We facilitate collaborative opportunities to refine, reduce, and replace animals in research. We are unique in growing ...See more See less
Founded in 1989, the New Jersey Association for Biomedical Research (NJABR), a 501(c)(3) non-profit, is the only organization in New Jersey dedicated solely to advocating for the continued availability of appropriate research models. Our membership consists of key stakeholders ...See more See less
The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here
Szczepan is a Comparative Medicine Veterinarian & Scientist turned "technology geek" who currently heads the Global Emerging Technologies (GET) within Comparative Medicine at Novartis. In this position, Szczepan leads integrated enterprise strategy for digital and non-digital ...See more See less
Natalie serves as 3Rs Scientific Liaison and Animal Welfare Specialist within AbbVie's Office of Global Animal Welfare. She earned a Master's degree in Cognitive and Behavioral Sciences from Illinois State University with an emphasis on applied behavior analysis. She's been with ...See more See less
Matt entered the research field over 20 years ago as a lab animal technician at the TSI/Mason contract research facility. He has worked at both contract facilities such as TSI and OREAD Biosafety as well in industry at Pharmacia, Pfizer, and Sanofi-Aventis. During that period he ...See more See less
Megan LaFollette is currently a 3Rs Fellow with The North American 3Rs Collaborative. She has her PhD in Animal Behavior & Well-Being from Purdue University, where she also received a Master of Science in Animal Welfare. Her primary interests lie at the intersection of ...See more See less
Tom Leach is an experienced biomedical research advocate, lobbyist, and non-profit association manager. Tom serves as the executive director of the Pennsylvania Society for Biomedical Research and the New Jersey Association for Biomedical Research. Tom has more than 20 years ...See more See less
John Lowman manages North American Business Development at Mimetas, from the stateside office located in Gaithersburg, Maryland. John is a biomedical engineering by training, with a career focus on start-up and scale-up biotech companies positioned to make robust societal ...See more See less
Dr. Perret-Gentil currently serves as University Veterinarian and Director of the Laboratory Animal Resources Center at the University of Texas at San Antonio. He is also the Attending Veterinarian for XENOSTART, Crown Scientific and the University of Texas of the Permian Basin ...See more See less
Laura Schaevitz, PhD, currently serves as VP at Recursion Pharmaceuticals. She is passionate about leveraging advanced sensor technology and machine learning capabilities to improve reproducibility and translatability of animal models. Drawing upon her expertise as a ...See more See less
Mary Ann Vasbinder, DVM, DACLAM, is the Global Head of Laboratory Animal Medicine at GlaxoSmithKline in Upper Providence, PA, in the In Vivo Biological Platform Technologies group. She oversees the global veterinary program for the US and UK sites. In this role she has led ...See more See less
Pelin is a tissue engineer by training having received her PhD in the field from Imperial College London. Soon after, oncology presented itself as a more interesting area to move into which led to the PostDoc position about circulating tumour cells at the UCL. Since then she has ...See more See less
Dr. Sandra J. Engle is currently Senior Director at Biogen where she leads the Translational Cellular Sciences group. Her team uses human stem cells, genomic engineering, electrophysiology, and microphysiological systems to develop in vitro models to enable drug discovery for ...See more See less
|Operating System||Internet Explorer||Firefox||Chrome||Safari|
|Windows 7||IE8+||FF10+||Chrome15+||Windows 8||IE10||FF10+||Chrome15+|
|Mac OS X||FF10+||Chrome15+||Safari5.1+|
- For viewing Webinars:
- For viewing Virtual Events
Research And Development
Labroots Registration (Also interested in)14%
WAVE Newsletter Promotion3%
Social Media Promotions1%
Animal Care Lab Technician6%
Medical Laboratory Technician6%
Clinical Laboratory Scientist2%
Contract Research Organization (Cro)3%
Life Science Company1%